Related Experiment Videos
HLA association with hepatitis C virus infection
S Vejbaesya1, S Songsivilai, T Tanwandee
1Department of Transfusion Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. sisve@mahidol.ac.th
Human Immunology
|February 26, 2000
Summary
Certain human leukocyte antigen (HLA) types are linked to persistent Hepatitis C Virus (HCV) infection in Thailand. HLA-DRB1*0301 and HLA-DQB1*0201 increase risk, while HLA-DRB1*0701 and HLA-DQA1*0201 may offer protection.
Area of Science:
- Immunogenetics
- Hepatology
- Infectious Diseases
Background:
- Hepatitis C Virus (HCV) infection poses a significant public health challenge in Thailand.
- Understanding host genetic factors influencing HCV infection outcomes is crucial for disease management.
- Limited data exists on the role of human leukocyte antigen (HLA) phenotypes in Thai populations with HCV.
Purpose of the Study:
- To investigate the association between HLA class I and II genotypes and the course of HCV infection in Thai individuals.
- To identify specific HLA alleles linked to transient versus persistent HCV infection.
Main Methods:
- Analysis of HLA class I and II phenotypes in two groups of Thai HCV patients: transient (n=43) and persistent (n=57).
- HLA class I typing utilized a 2-stage microlymphocytotoxicity test.
- HLA class II typing employed Polymerase Chain Reaction Sequence-Specific Oligonucleotide (PCR-SSO) probes.
Main Results:
- No significant differences in HLA-A and HLA-B antigen frequencies were found between transient and persistent HCV infection groups.
- Frequencies of HLA-DRB1*0301 and HLA-DQB1*0201 were significantly higher in the persistent infection group.
- Frequencies of HLA-DRB1*0701 and HLA-DQA1*0201 were significantly lower in all HCV-infected patients compared to healthy controls.
Conclusions:
- Specific HLA alleles are associated with differential outcomes of HCV infection in the Thai population.
- HLA-DRB1*0301 and HLA-DQB1*0201 are associated with an increased risk of persistent HCV infection.
- HLA-DRB1*0701 and HLA-DQA1*0201 may confer protection against HCV infection.